دورية أكاديمية
أعرض في EDS

Should we expect neurological symptoms in the SARS-CoV-2 epidemic?

التفاصيل البيبلوغرافية
العنوان: Should we expect neurological symptoms in the SARS-CoV-2 epidemic?
عنوان ترانسليتريتد: ¿Es esperable que haya cuadros neurológicos por la pandemia por SARS-CoV-2?
المؤلفون: Matías-Guiu J; Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, San Carlos, IdISSC, Madrid, España. Electronic address: neurol.hcsc@salud.madrid.org., Gomez-Pinedo U; Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, San Carlos, IdISSC, Madrid, España., Montero-Escribano P; Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, San Carlos, IdISSC, Madrid, España., Gomez-Iglesias P; Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, San Carlos, IdISSC, Madrid, España., Porta-Etessam J; Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, San Carlos, IdISSC, Madrid, España., Matias-Guiu JA; Servicio de Neurología, Instituto de Neurociencias, Hospital Clínico San Carlos, San Carlos, IdISSC, Madrid, España.
المصدر: Neurologia [Neurologia (Engl Ed)] 2020 Apr; Vol. 35 (3), pp. 170-175. Date of Electronic Publication: 2020 Apr 06.
نوع المنشور: Journal Article; Review
اللغة: English; Spanish; Castilian
بيانات الدورية: Publisher: Elsevier España Country of Publication: Spain NLM ID: 101778590 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2173-5808 (Electronic) Linking ISSN: 21735808 NLM ISO Abbreviation: Neurologia (Engl Ed) Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [Barcelona] : Elsevier España
مواضيع طبية MeSH: Central Nervous System/*virology , Coronavirus Infections/*physiopathology , Pneumonia, Viral/*physiopathology, Animals ; Betacoronavirus ; COVID-19 ; Coronavirus Infections/complications ; Disease Models, Animal ; Humans ; Mice ; Pandemics ; Pneumonia, Viral/complications ; SARS-CoV-2
مستخلص: Introduction: There is growing evidence that SARS-CoV-2 can gain access to the central nervous system (CNS). We revise the literature on coronavirus infection of the CNS associated with neurological diseases.
Development: Neurological symptoms were rarely reported in the SARS-CoV and MERS-CoV epidemics, although isolated cases were described. There are also reports of cases of neurological symptoms associated with CoV-OC43 and CoV-229E infection. The presence of neurological lesions, especially demyelinating lesions in the mouse hepatitis virus model, may explain the mechanisms by which coronaviruses enter the CNS, particularly those related with the immune response. This may explain the presence of coronavirus in patients with multiple sclerosis. We review the specific characteristics of SARS-CoV-2 and address the question of whether the high number of cases may be associated with greater CNS involvement.
Conclusion: Although neurological symptoms are not frequent in coronavirus epidemics, the high number of patients with SARS-CoV-2 infection may explain the presence of the virus in the CNS and increase the likelihood of early- or delayed-onset neurological symptoms. Follow-up of patients affected by the SARS-CoV-2 epidemic should include careful assessment of the CNS.
(Copyright © 2020 Sociedad Española de Neurología. Publicado por Elsevier España, S.L.U. All rights reserved.)
References: Emerg Infect Dis. 2004 Feb;10(2):342-4. (PMID: 15030709)
N Engl J Med. 2020 Mar 26;382(13):1199-1207. (PMID: 31995857)
Front Cell Neurosci. 2018 Oct 26;12:386. (PMID: 30416428)
Arch Neurol. 2004 Nov;61(11):1669-73. (PMID: 15534177)
Arch Neurol. 2005 Jul;62(7):1113-7. (PMID: 16009768)
Eur Rev Med Pharmacol Sci. 2020 Mar;24(5):2781-2783. (PMID: 32196628)
J Virol. 1997 Jan;71(1):800-6. (PMID: 8985420)
Hum Vaccin Immunother. 2019;15(2):496-502. (PMID: 30235060)
Chin Med J (Engl). 2020 May 5;133(9):1025-1031. (PMID: 32044814)
J Virol. 1999 Apr;73(4):3326-37. (PMID: 10074187)
J Infect Dis. 2013 Jun 1;207(11):1743-52. (PMID: 23532101)
J Med Virol. 2020 Jun;92(6):552-555. (PMID: 32104915)
Acta Neuropathol. 2001 Jun;101(6):601-4. (PMID: 11515789)
Case Rep Neurol Med. 2016;2016:3502683. (PMID: 27239356)
J Virol. 1999 Apr;73(4):3338-50. (PMID: 10074188)
Adv Exp Med Biol. 1998;440:635-9. (PMID: 9782339)
Virology. 2009 Dec 20;395(2):255-67. (PMID: 19846189)
Virology. 1992 Nov;191(1):502-5. (PMID: 1413524)
Emerg Microbes Infect. 2020 Dec;9(1):221-236. (PMID: 31987001)
Neurology. 2003 Dec 23;61(12):1820-1. (PMID: 14694063)
J Neurol. 2004 Oct;251(10):1227-31. (PMID: 15503102)
Mov Disord. 1992;7(2):153-8. (PMID: 1316552)
J Neuroimmune Pharmacol. 2009 Jun;4(2):200-12. (PMID: 19016329)
JAMA. 2020 Mar 17;323(11):1061-1069. (PMID: 32031570)
J Virol. 2000 Oct;74(19):8913-21. (PMID: 10982334)
J Virol. 2015 Oct;89(19):9896-908. (PMID: 26202229)
Crit Rev Immunol. 2010;30(2):119-30. (PMID: 20370625)
Int J Antimicrob Agents. 2020 Mar;55(3):105924. (PMID: 32081636)
Clin Infect Dis. 2020 Dec 3;71(9):2428-2446. (PMID: 32215622)
BMJ. 2020 Feb 19;368:m606. (PMID: 32075786)
Cureus. 2020 Mar 21;12(3):e7352. (PMID: 32328364)
Virus Res. 2014 Dec 19;194:145-58. (PMID: 25281913)
Adv Virus Res. 2018;100:163-188. (PMID: 29551135)
J Virol. 2016 Dec 16;91(1):. (PMID: 27795420)
Adv Exp Med Biol. 2014;807:75-96. (PMID: 24619619)
Saudi Med J. 2017 Feb;38(2):196-200. (PMID: 28133694)
Virus Res. 2015 Apr 16;202:89-100. (PMID: 25432065)
ACS Chem Neurosci. 2020 Apr 1;11(7):995-998. (PMID: 32167747)
Front Immunol. 2018 Dec 20;9:3022. (PMID: 30619363)
Pediatrics. 2004 Jan;113(1 Pt 1):e73-6. (PMID: 14702500)
J Gen Virol. 1995 Dec;76 ( Pt 12):3201-4. (PMID: 8847530)
J Pediatr Neurosci. 2015 Jul-Sep;10(3):280-1. (PMID: 26557177)
Ann Neurol. 1992 May;31(5):525-33. (PMID: 1596089)
PLoS One. 2014 Oct 31;9(10):e111351. (PMID: 25360880)
J Gen Virol. 1982 Jun;60(Pt 2):307-14. (PMID: 7108490)
Arch Virol. 1992;122(1-2):35-44. (PMID: 1309644)
Neurology. 1982 Mar;32(3):292-5. (PMID: 6278362)
Microb Pathog. 1994 May;16(5):349-57. (PMID: 7815918)
J Virol. 2018 Aug 16;92(17):. (PMID: 29925652)
J Can Chiropr Assoc. 2011 Mar;55(1):32-9. (PMID: 21403780)
Science. 1980 Aug 22;209(4459):933-4. (PMID: 7403860)
Eur J Clin Microbiol Infect Dis. 2007 Feb;26(2):121-9. (PMID: 17219094)
Curr Top Microbiol Immunol. 2001;253:247-71. (PMID: 11417138)
Lab Invest. 1988 Jan;58(1):31-6. (PMID: 2826881)
J Neurol Sci. 1976 May;28(1):121-6. (PMID: 932771)
J Virol. 2012 Jan;86(1):81-93. (PMID: 22013052)
SAGE Open Med Case Rep. 2019 Mar 21;7:2050313X19838750. (PMID: 30915222)
Lancet. 2020 Feb 15;395(10223):497-506. (PMID: 31986264)
Int J Infect Dis. 2014 Dec;29:301-6. (PMID: 25303830)
N Engl J Med. 2016 Aug 4;375(5):497-8. (PMID: 27518687)
Infection. 2015 Aug;43(4):495-501. (PMID: 25600929)
J Clin Neurol. 2017 Jul;13(3):227-233. (PMID: 28748673)
Biochem Biophys Res Commun. 2004 Jul 9;319(4):1216-21. (PMID: 15194496)
Lancet. 1985 Jun 8;1(8441):1313-5. (PMID: 2860501)
Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):2162-2164. (PMID: 32141586)
Lancet. 2020 Feb 15;395(10223):507-513. (PMID: 32007143)
Virology. 1984 Sep;137(2):347-57. (PMID: 6091333)
Adv Exp Med Biol. 1987;218:287-95. (PMID: 2829542)
PLoS Curr. 2013 Nov 12;5:. (PMID: 24270606)
Virology. 2003 Oct 10;315(1):20-33. (PMID: 14592756)
Nat Rev Immunol. 2011 May;11(5):318-29. (PMID: 21508982)
Emerg Microbes Infect. 2020 Dec;9(1):386-389. (PMID: 32065057)
J Neurol. 1993 Jul;240(7):417-22. (PMID: 8410082)
Virology. 2006 Jun 5;349(2):335-46. (PMID: 16527322)
J Neurovirol. 2005 Aug;11(4):395-402. (PMID: 16162482)
Methods Mol Biol. 2015;1282:1-23. (PMID: 25720466)
Acta Neurol Taiwan. 2005 Sep;14(3):113-9. (PMID: 16252612)
Virology. 2007 Oct 25;367(2):367-74. (PMID: 17631932)
Microbes Infect. 2020 Mar;22(2):69-71. (PMID: 32032682)
Lancet Respir Med. 2020 May;8(5):475-481. (PMID: 32105632)
Clin Microbiol Rev. 2007 Jan;20(1):49-78. (PMID: 17223623)
New Microbiol. 1997 Apr;20(2):105-14. (PMID: 9208420)
Intervirology. 2016;59(3):163-169. (PMID: 28103598)
فهرسة مساهمة: Keywords: Central nervous system; Coronavirus; Esclerosis múltiple; MERS-CoV; Mouse hepatitis virus; Multiple sclerosis; Neurological symptoms; SARS-CoV; SARS-CoV-2; Sistema nervioso central; Síntomas neurológicos; Virus murino de la hepatitis
تواريخ الأحداث: Date Created: 20200418 Date Completed: 20200504 Latest Revision: 20210527
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC7136883
DOI: 10.1016/j.nrl.2020.03.001
PMID: 32299636
قاعدة البيانات: MEDLINE
الوصف
تدمد:2173-5808
DOI:10.1016/j.nrl.2020.03.001